These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27178938)

  • 1. Targeted delivery of small interfering RNA to colon cancer cells using chitosan and PEGylated chitosan nanoparticles.
    Rudzinski WE; Palacios A; Ahmed A; Lane MA; Aminabhavi TM
    Carbohydr Polym; 2016 Aug; 147():323-332. PubMed ID: 27178938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan-poly(ethylene imine) hybrid nanoparticles: A mechanistic insight.
    Ragelle H; Colombo S; Pourcelle V; Vanvarenberg K; Vandermeulen G; Bouzin C; Marchand-Brynaert J; Feron O; Foged C; Préat V
    J Control Release; 2015 Aug; 211():1-9. PubMed ID: 25989603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
    Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
    Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of siRNA targeting tumor metabolism using non-covalent PEGylated chitosan nanoparticles: Identification of an optimal combination of ligand structure, linker and grafting method.
    Corbet C; Ragelle H; Pourcelle V; Vanvarenberg K; Marchand-Brynaert J; Préat V; Feron O
    J Control Release; 2016 Feb; 223():53-63. PubMed ID: 26699426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.
    Ragelle H; Riva R; Vandermeulen G; Naeye B; Pourcelle V; Le Duff CS; D'Haese C; Nysten B; Braeckmans K; De Smedt SC; Jérôme C; Préat V
    J Control Release; 2014 Feb; 176():54-63. PubMed ID: 24389132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small interfering RNA-loaded chitosan hydrochloride/carboxymethyl chitosan nanoparticles for ultrasound-triggered release to hamper colorectal cancer growth in vitro.
    Yan L; Gao S; Shui S; Liu S; Qu H; Liu C; Zheng L
    Int J Biol Macromol; 2020 Nov; 162():1303-1310. PubMed ID: 32603733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases.
    Malhotra M; Tomaro-Duchesneau C; Prakash S
    Biomaterials; 2013 Jan; 34(4):1270-80. PubMed ID: 23140978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of Fe
    Arami S; Rashidi MR; Mahdavi M; Fathi M; Entezami AA
    Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression.
    Salimifard S; Karoon Kiani F; Sadat Eshaghi F; Izadi S; Shahdadnejad K; Masjedi A; Heydari M; Ahmadi A; Hojjat-Farsangi M; Hassannia H; Mohammadi H; Boroumand-Noughabi S; Keramati MR; Jadidi-Niaragh F
    Life Sci; 2020 Nov; 260():118423. PubMed ID: 32941896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated poly-l-arginine derivatives of chitosan for effective delivery of siRNA.
    Noh SM; Park MO; Shim G; Han SE; Lee HY; Huh JH; Kim MS; Choi JJ; Kim K; Kwon IC; Kim JS; Baek KH; Oh YK
    J Control Release; 2010 Jul; 145(2):159-64. PubMed ID: 20385182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant blockade of A2AR and CTLA-4 by siRNA-loaded polyethylene glycol-chitosan-alginate nanoparticles synergistically enhances antitumor T-cell responses.
    Ghasemi-Chaleshtari M; Kiaie SH; Irandoust M; Karami H; Nabi Afjadi M; Ghani S; Aghaei Vanda N; Ghaderi Sede MJ; Ahmadi A; Masjedi A; Hassannia H; Atyabi F; Hojjat-Farsangi M; Namdar A; Ghalamfarsa G; Jadidi-Niaragh F
    J Cell Physiol; 2020 Dec; 235(12):10068-10080. PubMed ID: 32488862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted siRNA delivery by anti-HER2 antibody-modified nanoparticles of mPEG-chitosan diblock copolymer.
    Wang Y; Liu P; Du J; Sun Y; Li F; Duan Y
    J Biomater Sci Polym Ed; 2013; 24(10):1219-32. PubMed ID: 23713424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery.
    Ping Y; Liu C; Zhang Z; Liu KL; Chen J; Li J
    Biomaterials; 2011 Nov; 32(32):8328-41. PubMed ID: 21840593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
    Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
    Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA.
    Malhotra M; Tomaro-Duchesneau C; Saha S; Kahouli I; Prakash S
    Int J Nanomedicine; 2013; 8():2041-52. PubMed ID: 23723699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic gold nanoparticle-mediated small interference RNA silencing Bag-1 gene for colon cancer therapy.
    Huang W; Liu Z; Zhou G; Tian A; Sun N
    Oncol Rep; 2016 Feb; 35(2):978-84. PubMed ID: 26717967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment.
    Lee SJ; Huh MS; Lee SY; Min S; Lee S; Koo H; Chu JU; Lee KE; Jeon H; Choi Y; Choi K; Byun Y; Jeong SY; Park K; Kim K; Kwon IC
    Angew Chem Int Ed Engl; 2012 Jul; 51(29):7203-7. PubMed ID: 22696263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
    Gu J; Al-Bayati K; Ho EA
    Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence Supporting the Safety of Pegylated Diethylaminoethyl-Chitosan Polymer as a Nanovector for Gene Therapy Applications.
    Rondon EP; Benabdoun HA; Vallières F; Segalla Petrônio M; Tiera MJ; Benderdour M; Fernandes JC
    Int J Nanomedicine; 2020; 15():6183-6200. PubMed ID: 32922001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.